THE USE OF GONADOTROPIN-RELEASING HORMONE AGONISTS AND THE EFFICIENCY OF IN VITRO FERTILIZATION

Pasquale Patrizio, Sanaz Ghazal, Judith A. F. Huirne, Roel Schats

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

Abstract

Gonadotropin-releasing hormone (GnRH) is the primary hypothalamic regulator of reproductive function. The chemical structure of this compound was discovered in 1971 by a group of scientists in Andrew Schally’s laboratory in New Orleans after they derived a small amount of GnRH from porcine hypothalami [1, 2]. Roger Guillemin then characterized and independently synthesized the hormone, and he and Schally received the Nobel Prize for their achievements. GnRH is a decapeptide that is synthesized as part of a much larger precursor peptide, the GnRH-associated peptide. This peptide is composed of a sequence of 56 amino acids. The availability of the synthetic hormone for dynamic endocrine testing and receptor studies created new insights into the physiological role of GnRH in the hypothalamic-pituitary-gonadal axis [3].
Original languageEnglish
Title of host publicationTextbook of Assisted Reproductive Techniques: Volume 2: Clinical Perspectives, Sixth Edition
PublisherCRC Press
Pages463-471
Volume2
ISBN (Electronic)9781000933505
ISBN (Print)9781032214801
DOIs
Publication statusPublished - 1 Jan 2023

Publication series

NameTextbook of Assisted Reproductive Techniques: Volume 2: Clinical Perspectives, Sixth Edition

Cite this